188 related articles for article (PubMed ID: 37450572)
1. O2L-001, an innovative thrombolytic to evacuate intracerebral haematoma.
Thiebaut AM; Louet ER; Ianszen M; Guichard MJ; Hanley DF; Gaudin C; Parcq J
Brain; 2023 Nov; 146(11):4690-4701. PubMed ID: 37450572
[TBL] [Abstract][Full Text] [Related]
2. Effect of irrigation on fibrinolytic rtPA therapy in a clot model of intracerebral haemorrhage: a systematic in vitro study.
Masomi-Bornwassser J; Freguia F; Müller-Werkmeister H; Kempski O; Giese A; Keric N
Acta Neurochir (Wien); 2018 Jun; 160(6):1159-1165. PubMed ID: 29564653
[TBL] [Abstract][Full Text] [Related]
3. Preliminary findings of the minimally-invasive surgery plus rtPA for intracerebral hemorrhage evacuation (MISTIE) clinical trial.
Morgan T; Zuccarello M; Narayan R; Keyl P; Lane K; Hanley D
Acta Neurochir Suppl; 2008; 105():147-51. PubMed ID: 19066101
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, randomized, double-blinded, placebo-controlled phase III study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III).
Ziai WC; Tuhrim S; Lane K; McBee N; Lees K; Dawson J; Butcher K; Vespa P; Wright DW; Keyl PM; Mendelow AD; Kase C; Wijman C; Lapointe M; John S; Thompson R; Thompson C; Mayo S; Reilly P; Janis S; Awad I; Hanley DF;
Int J Stroke; 2014 Jun; 9(4):536-42. PubMed ID: 24033910
[TBL] [Abstract][Full Text] [Related]
5. Optimized tPA: A non-neurotoxic fibrinolytic agent for the drainage of intracerebral hemorrhages.
Goulay R; Naveau M; Gaberel T; Vivien D; Parcq J
J Cereb Blood Flow Metab; 2018 Jul; 38(7):1180-1189. PubMed ID: 28741405
[TBL] [Abstract][Full Text] [Related]
6. Future perspectives on the fibrinolytic therapy of intracerebral hemorrhages.
Thiex R
Cent Nerv Syst Agents Med Chem; 2011 Jun; 11(2):150-6. PubMed ID: 21521167
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of fibrinolytic properties of Alteplase, Tenecteplase and Urokinase in an in vitro clot model of intracerebral haemorrhage.
Keric N; Döbel M; Krenzlin H; Kurz E; Tanyildizi Y; Heimann A; König J; Kempski O; Ringel F; Masomi-Bornwasser J
J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105073. PubMed ID: 32807475
[TBL] [Abstract][Full Text] [Related]
8. Comparison of plasmin with recombinant tissue-type plasminogen activator in lysis of cerebral thromboemboli retrieved from patients with acute ischemic stroke.
Marder VJ; Blinc A; Gruber T; Tratar G; Sabovic M; Starkman S; Jahan R; Duckwiler G; Vinuela F; Tateshima S; Liebeskind D; Ovbiagele B; Ali L; Kim D; Gonzalez N; Vespa PM; Saver JL
Stroke; 2011 Aug; 42(8):2222-8. PubMed ID: 21700944
[TBL] [Abstract][Full Text] [Related]
9. Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial.
Fam MD; Hanley D; Stadnik A; Zeineddine HA; Girard R; Jesselson M; Cao Y; Money L; McBee N; Bistran-Hall AJ; Mould WA; Lane K; Camarata PJ; Zuccarello M; Awad IA
Neurosurgery; 2017 Nov; 81(5):860-866. PubMed ID: 28402516
[TBL] [Abstract][Full Text] [Related]
10. Catheter placement for lysis of spontaneous intracerebral hematomas: does a catheter position in the core of the hematoma allow more effective and faster hematoma lysis?
Malinova V; Schlegel A; Rohde V; Mielke D
Neurosurg Rev; 2017 Jul; 40(3):397-402. PubMed ID: 27726038
[TBL] [Abstract][Full Text] [Related]
11. Management of delayed edema formation after fibrinolytic therapy for intracerebral hematomas: preliminary experimental data.
Rohde V; Uzma N; Thiex R; Samadani U
Acta Neurochir Suppl; 2008; 105():101-4. PubMed ID: 19066092
[TBL] [Abstract][Full Text] [Related]
12. Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial.
Naff N; Williams MA; Keyl PM; Tuhrim S; Bullock MR; Mayer SA; Coplin W; Narayan R; Haines S; Cruz-Flores S; Zuccarello M; Brock D; Awad I; Ziai WC; Marmarou A; Rhoney D; McBee N; Lane K; Hanley DF
Stroke; 2011 Nov; 42(11):3009-16. PubMed ID: 21868730
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial.
Hanley DF; Thompson RE; Rosenblum M; Yenokyan G; Lane K; McBee N; Mayo SW; Bistran-Hall AJ; Gandhi D; Mould WA; Ullman N; Ali H; Carhuapoma JR; Kase CS; Lees KR; Dawson J; Wilson A; Betz JF; Sugar EA; Hao Y; Avadhani R; Caron JL; Harrigan MR; Carlson AP; Bulters D; LeDoux D; Huang J; Cobb C; Gupta G; Kitagawa R; Chicoine MR; Patel H; Dodd R; Camarata PJ; Wolfe S; Stadnik A; Money PL; Mitchell P; Sarabia R; Harnof S; Barzo P; Unterberg A; Teitelbaum JS; Wang W; Anderson CS; Mendelow AD; Gregson B; Janis S; Vespa P; Ziai W; Zuccarello M; Awad IA;
Lancet; 2019 Mar; 393(10175):1021-1032. PubMed ID: 30739747
[TBL] [Abstract][Full Text] [Related]
14. Emergency Free-Hand Bedside Catheter Evacuation of Large Intracerebral Hematomas Following Thrombolysis for Ischemic Stroke: A Case Series.
Bardutzky J; Shah M; Lambeck J; Meckel S; Niesen WD
Neurocrit Care; 2020 Aug; 33(1):207-217. PubMed ID: 31797279
[TBL] [Abstract][Full Text] [Related]
15. Early Quantification of Hematoma Hounsfield Units on Noncontrast CT in Acute Intraventricular Hemorrhage Predicts Ventricular Clearance after Intraventricular Thrombolysis.
Kornbluth J; Nekoovaght-Tak S; Ullman N; Carhuapoma JR; Hanley DF; Ziai W
AJNR Am J Neuroradiol; 2015 Sep; 36(9):1609-15. PubMed ID: 26228884
[TBL] [Abstract][Full Text] [Related]
16. Minimally invasive evacuation of spontaneous intracerebral hemorrhage using sonothrombolysis.
Newell DW; Shah MM; Wilcox R; Hansmann DR; Melnychuk E; Muschelli J; Hanley DF
J Neurosurg; 2011 Sep; 115(3):592-601. PubMed ID: 21663412
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial.
Hanley DF; Thompson RE; Muschelli J; Rosenblum M; McBee N; Lane K; Bistran-Hall AJ; Mayo SW; Keyl P; Gandhi D; Morgan TC; Ullman N; Mould WA; Carhuapoma JR; Kase C; Ziai W; Thompson CB; Yenokyan G; Huang E; Broaddus WC; Graham RS; Aldrich EF; Dodd R; Wijman C; Caron JL; Huang J; Camarata P; Mendelow AD; Gregson B; Janis S; Vespa P; Martin N; Awad I; Zuccarello M;
Lancet Neurol; 2016 Nov; 15(12):1228-1237. PubMed ID: 27751554
[TBL] [Abstract][Full Text] [Related]
18. Optimization of Catheter Based rtPA Thrombolysis in a Novel In Vitro Clot Model for Intracerebral Hemorrhage.
Keric N; Masomi-Bornwasser J; Müller-Werkmeister H; Kantelhardt SR; König J; Kempski O; Giese A
Biomed Res Int; 2017; 2017():5472936. PubMed ID: 28459065
[TBL] [Abstract][Full Text] [Related]
19. The Quinazoline Otaplimastat (SP-8203) Reduces the Hemorrhagic Transformation and Mortality Aggravated after Delayed rtPA-Induced Thrombolysis in Cerebral Ischemia.
Song HY; Chung JI; Jalin AMA; Ju C; Pahk K; Joung C; Lee S; Jin S; Kim BS; Lee KS; Ryu JM; Kim WK
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163322
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Cerebroprotection of Xenon-Loaded Liposomes in Combination with rtPA Thrombolysis for Embolic Ischemic Stroke.
Peng T; Booher K; Moody MR; Yin X; Aronowski J; McPherson DD; Savitz SI; Kim H; Huang SL
Biomolecules; 2023 Aug; 13(8):. PubMed ID: 37627321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
